Live feed16:34:41·302dINSIDERFilingvia QuantisnowPresident and CEO Litton Mark James converted options into 108,334 shares and sold $7,374 worth of shares (25,123 units at $0.29), increasing direct ownership by 34% to 325,802 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.ATHA· Athira Pharma Inc.Health CareOriginal source